1.A Study of the Way to Ameliorate Living Habits-For People With Hyperlipidemia-
Kayo SOGA ; Noriko MATSUMOTO ; Yumi SAHO ; Akiko ADACHI ; Takayo NAKAURA ; Mitsunobu AKASHI
Journal of the Japanese Association of Rural Medicine 2003;52(1):53-64
As a strategy for making people in enjoy good health by preventing disease, various forms of guidance for improvement of lifestyle have been recently been introduced. The purpose of the health guidance is to help people who do not have a disease but have abnormality in their physical examination data change their behavior patterns of daily living habits.
In this study, we chose local residents with hyperlipidemia as the subjects of this study and carried out the guidance for one year for improvement of their lifestyle focusing eating habits and physical exercise in order to improve their serum lipid levels. We looked at the effects of this intervention activity on their conciousness and behavior, and the values of their body weight, body fat and other biochemical blood test results. When their living habits between before and after our intervention activity were compared, the residents had more interested in meals and physical exercises, and improved their dietary habits, especially on the in take of eggs, vegetables, eating between meals and salt. In addition, analysis of residents' nutritive values supported this result.
Our investigation also indicated a tendency of increase in the frequency of physical exercise expect for working time after our intervention activity. The values of total cholesterol, body weight, obesity and fasting blood sugar in the general and blood examinations significantly reduced.
Altogether, our intervention activity proved to be effective in changing people's conciousness and personal lifestyle at, and improving the values of body weight and serum lipid.
2.Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients.
Shinji OGIHARA ; Ryoichi SAITO ; Teru AKIKURA ; Akiko IWAMA ; Yukari ADACHI ; Daiki KAJI ; Kyoka KAKINUMA ; Hiroshi TAKAHASHI
Annals of Laboratory Medicine 2015;35(4):410-415
BACKGROUND: Streptococcus pneumoniae causes pneumonia, sepsis, and meningitis. This study aimed to investigate the clinical characteristics of mucoid and non-mucoid isolates of S. pneumoniae, and to explore the relationship between the isolate phenotypes and their antibiotic susceptibility. METHODS: Clinical isolates from 3,453 non-repetitive S. pneumoniae (189 mucoid and 3,264 non-mucoid) infections obtained between January 2008 and December 2012 from outpatients at the Kimitsu-Central Hospital were evaluated. RESULTS: Compared to the non-mucoid isolates, the mucoid phenotypes were more susceptible to certain antibiotics such as erythromycin, clarithromycin, and tetracycline as opposed to clindamycin, chloramphenicol, and rifampicin. The mucoid phenotype was isolated more frequently from schoolchildren, adults, and elderly adults in a variety of clinical sites, including otorrhea, genitalia, pus, and eye discharge than the non-mucoid phenotype. This suggested that mucoid isolates are more likely to be involved than non-mucoid isolates in various local infections. Systemic infection, which indicates invasiveness, was not associated with the mucoid or non-mucoid phenotype. CONCLUSIONS: The results of this study suggest that mucoid isolates tend to have higher susceptibility than non-mucoid isolates to antibiotics. To the best of our knowledge, mucoid and non-mucoid S. pneumoniae isolates considerably differ in terms of clinical isolation site and age-specific prevalence.
Adult
;
Aged
;
Anti-Bacterial Agents
;
Chloramphenicol
;
Clarithromycin
;
Clindamycin
;
Erythromycin
;
Genitalia
;
Humans
;
Meningitis
;
Outpatients*
;
Phenotype
;
Pneumonia
;
Prevalence
;
Rifampin
;
Sepsis
;
Streptococcus pneumoniae*
;
Suppuration
;
Tetracycline
3.Analysis of Pharmaceutical Interventions for pregnant Inpatients
Makiko ADACHI ; Hiroshi TAKANE ; Kazuko INOUE ; Akiko TAKAHASHI ; Miki SHIMADA
Japanese Journal of Drug Informatics 2022;24(2):130-137
Objective: There is little information on the effectiveness and safety of health foods for pregnant women. The purpose of this study was to analyze the risk of health food to pregnant women and fetuses from pharmaceutical interventions and clarify the problems for standardization of pharmaceutical management and guidance.Methods: Among 243 pregnant inpatients who received consultations from our pharmacists, 61 subjects were taking health food products were recruited from May 2015 to April 2017. We developed novel guidelines for the use of health food products for pregnant women, and used the guidelines to provide pharmaceutical interventions. Results of these interventions were reviewed retrospectively to identify issues associated with pharmaceutical management of the use of health food products.Results: Among 61 subjects, 10 (16%) received a total of 11 interventions for the use of health food products. Suggestions to discontinue the use of health food products were accepted by 9 subjects (82%). The majority of interventions (n=7, 64%) were related to therapeutic disadvantages of health food products, such as “bleeding complications during childbirth” and “interaction with other medicines”. Information on the number of weeks of pregnancy, drug history, and treatment status were used to trigger and determine appropriate pharmaceutical interventions.Conclusion: From the intervention cases, the potential disadvantages associated with the use of health foods were confirmed, and the risk status of pregnant women and fetuses associated with the use of health foods was clarified. It is necessary to intervene before embarking on using health foods, to make judgements based on risk assessment considering the number of weeks of pregnancy and patient background, and to provide accurate information to pregnant women. We anticipate that future studies will provide additional insights into the effects of health food intake on pregnant women, and that support systems for pregnant women will be established by medical professionals.
4.Lower albumin levels are associated with frailty measures, trace elements, and an inflammation marker in a cross-sectional study in Tanushimaru.
Maki YAMAMOTO ; Hisashi ADACHI ; Mika ENOMOTO ; Ako FUKAMI ; Sachiko NAKAMURA ; Yume NOHARA ; Akiko SAKAUE ; Nagisa MORIKAWA ; Hitoshi HAMAMURA ; Kenta TOYOMASU ; Yoshihiro FUKUMOTO
Environmental Health and Preventive Medicine 2021;26(1):25-25
BACKGROUND:
There is little data on the association between the lower nutrition represented by serum albumin levels and related factors in a general population. The present study aimed to determine whether the albumin level positioned as some kind of biomarker with frailty measures, trace elements, and an inflammation marker.
METHODS:
In 2018, we performed an epidemiological survey in 1368 subjects who resided in Tanushimaru, Japan, in which we examined the blood chemistry including albumin, trace elements, hormone levels, and carotid ultrasonography. Albumin levels were categorized into 4 groups (G1 [3.2-3.9 mg/dL], G2 [4.0-4.3 mg/dL], G3 [4.4-4.6 mg/dL], and G4 [4.7-5.3 mg/dL]). The participants underwent measurements of handgrip strength and were tested by asking to walk 5 m. Their cognitive functions were evaluated by the mini-mental state examination (MMSE).
RESULTS:
Multiple stepwise regression analysis demonstrated that albumin levels were significantly and independently associated with age (inversely), systolic blood pressures, estimated glomerular filtration rate (eGFR), MMSE score, frailty measures (handgrip strength), an inflammation marker (high-sensitivity C-reactive protein), hormones (growth hormone (inversely) and insulin-like growth factor-1), and trace elements (calcium, magnesium, iron, and zinc), with a linear trend.
CONCLUSIONS
Lower albumin levels, even in the normal range, were found to be related factors of frailty measures, trace elements, and an inflammation marker in a general population.
Aged
;
Albumins/metabolism*
;
Biomarkers/blood*
;
Cross-Sectional Studies
;
Female
;
Frailty/physiopathology*
;
Hand Strength/physiology*
;
Humans
;
Inflammation/blood*
;
Japan
;
Male
;
Trace Elements/blood*
5.Correlation between estimated plasma remnant-like particle cholesterol and vegetable fat intake in Uku town, Japan.
Hisashi ADACHI ; Tatsuyuki KAKUMA ; Mika ENOMOTO ; Ako FUKAMI ; Sachiko NAKAMURA ; Yume NOHARA ; Nagisa MORIKAWA ; Akiko SAKAUE ; Maki YAMAMOTO ; Yoshihiro FUKUMOTO
Environmental Health and Preventive Medicine 2021;26(1):82-82
BACKGROUND:
Remnant-like particle cholesterol (RLP-C) is highly atherogenic, which is associated with atherosclerosis. However, RLP-C has not been routinely measured in the clinical practice. We estimated RLP-C levels using conventional lipid profiles and examined the association between estimated RLP-C and related factors including nutrient intake.
METHODS:
This study was performed in Uku town, Nagasaki prefecture, Japan in 2019. A total of 225 subjects were enrolled and directly measured RLP-C levels. Estimated RLP-C levels were defined as the following formula [total cholesterol - (LDL-cholesterol) - (HDL-cholesterol)]. Multivariate analyses were used to assess the relationship between estimated RLP-C and atherogenic factors. We calculated cut-off values on dichotomized RLP-C (< 7.5 mg/dL vs. ≥ 7.5 mg/dL) by receiver operating characteristic (ROC) curve.
RESULTS:
The mean values of directly measured RLP-C levels and estimated RLP-C were 4.0 mg/dL and 16.4 mg/dL, respectively. In the multiple stepwise linear regression analysis, directly measured and estimated RLP-C levels were independently and commonly associated with apolipoprotein E, triglycerides, and vegetable fat intake (inversely). Using ROC curves, we found the cut-off value of estimated RLP-C was 22.0 mg/dL.
CONCLUSION
We demonstrated that the estimated RLP-C levels using conventional lipid profiles may substitute for directly measured RLP-C and these levels were independently and inversely associated with vegetable fat intake in the community-dwelling Japanese population.
Aged
;
Aged, 80 and over
;
Cholesterol/blood*
;
Dietary Fats/blood*
;
Female
;
Humans
;
Japan
;
Lipids/blood*
;
Lipoproteins/blood*
;
Male
;
Middle Aged
;
Triglycerides/blood*
;
Vegetables